EyePromise®, the leading provider of evidence-based nutritional supplements for eye health, is pleased to announce the appointment of Dr. Pinakin Davey as its new Chief Medical & Science Officer. Dr. Davey brings a wealth of experience and expertise in optometry, clinical research, and nutritional science to further enhance EyePromise's commitment to advancing eye health through innovative solutions.

Responsibilities

As the Chief Medical and Science Officer, Dr. Davey will play a pivotal role in shaping and driving EyePromise’s scientific and medical initiatives. His responsibilities will include overseeing the development and clinical evaluation of EyePromise's nutritional products and technology, collaborating with renowned experts in the field, and guiding the company's research and development efforts.Dr. Pinakin Davey will also remain in his current position as a tenured Professor at Western University of Health Sciences, College of Optometry.

Dr. Davey is a highly accomplished professional who holds a Doctor of Optometry degree from Southern College of Optometry and a Ph.D. from Anglia Ruskin University in Cambridge, England, in corneal biomechanics and its influence on glaucoma related measurements.

His post-doctoral research fellowship at the University of Louisville for three years was focused on improving imaging techniques in glaucoma. He has authored over 75 international publications and has given over 500 conference and invited presentations both nationally and internationally. Dr. Davey’s research area is focused on retinal and optic nerve physiology and research methods of improving vision in patients with glaucoma and macular degeneration. Dr. Davey is a fellow of American Academy of Optometry (AAO), a fellow of Association for Research in Vision and Ophthalmology (ARVO), a member of Optometric Glaucoma Society (OGS) and the American Optometric Association (AOA).

Dr. Davey said,

"I am thrilled to be joining EyePromise and working alongside such a talented team. I have long been impressed by EyePromise and its co-founder Dr. Dennis Gierhart’s commitment to providing science-backed nutritional solutions for eye health. I look forward to contributing my expertise to drive innovation, further expand the broadest product portfolio on the market, and improve the lives of individuals worldwide by educating on our measurable ocular nutrition solutions for optimal vision. It’s an exciting time to be a part of the EyePromise team as they successfully launch the industry leading Zx Pro™, a diagnostic macular pigment optical density (MPOD) tool designed to measure and track MPOD values."

What This Change Means for the Future

EyePromise has earned a strong reputation for its evidence-based supplements formulated to support eye health, including products designed explicitly for macular health, occasional dry eye, and visual performance. With Dr. Davey's addition to the team, EyePromise aims to accelerate its position as the leader in the eye health industry by continuously advancing its scientific understanding and delivering premium, high-quality products and solutions that meet consumers’ evolving needs.

EyePromise President Andreas Wolf said,

"We are thrilled to welcome Dr. Davey to EyePromise as our Chief Medical and Science Officer. His deep knowledge of medical optometry, clinical research, and nutrition will greatly strengthen our scientific foundation and accelerate our mission of providing innovative solutions for eye health. We are confident that Dr. Davey's expertise and leadership will guide us towards new breakthroughs and further establish EyePromise as the trusted authority in the field."

Dr. Davey's appointment comes at an exciting time for EyePromise as the company continues to expand its reach and impact within the eye health industry. With his leadership, EyePromise is poised to revolutionize the field of nutritional eye health and improve the lives of millions worldwide.